CollabRx and Cynvenio Partner in Molecular Diagnostics for Cancer
December 11, 2013 09:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Dec. 11, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Cynvenio Biosystems,...
CollabRx to Present at the LD MICRO Sixth Annual Conference
November 20, 2013 14:36 ET
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 20, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R....
CollabRx Reports Second Quarter Fiscal Year 2014 Financial Results
November 13, 2013 16:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 13, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the second quarter of fiscal year 2014, which ended September 30,...
CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing
November 11, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 11, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a...
CollabRx, Inc. Schedules Second Quarter Fiscal Year 2014 Financial Conference Call and Business Update
November 05, 2013 09:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on November...
CollabRx to Present at LD MICRO Invitational on October 2nd
September 26, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Sept. 26, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R....
CollabRx Appoints George Lundberg, M.D. as Chief Medical Officer
September 04, 2013 09:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Sept. 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of George Lundberg, M.D. as its Chief Medical Officer. Dr. Lundberg will continue in his...
CollabRx Reports First Quarter Fiscal Year 2014 Financial Results
August 13, 2013 16:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the first quarter of fiscal year 2014, which ended June 30,...
CollabRx Announces Oncology-Specific Mobile App With Leading Site for Healthcare Professionals, MedPage Today
August 13, 2013 09:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a healthcare information technology company focused on informing clinical decision making in molecular medicine, today...
CollabRx Launches Commercial Service for the Interpretation of Clinical Cancer Sequencing
August 08, 2013 09:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 8, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced the launch...